Incannex Healthcare
Develops combination medicines and a psilocybin-assisted therapy candidate for chronic diseases.
$3.66
After-hours close+0.01 (+0.27%)
At close$3.65(−1.08%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 10.79%1.29M sharesInsiders 12.07%1.44M sharesOther 77.14%9.23M shares
Shares outstanding 11.96M · Float 9.87M · 82.5% free float
A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.
Institutions13F, as of Mar 31, 2026
20 holders · 1.29M shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 625.0K | 5.22% | May 15, 2026 | |
| Ghisallo Capital Management LLC | 162.9K | 1.36% | May 15, 2026 | |
| Mirae Asset Global Etfs Holdings Ltd. | 149.9K | 1.25% | May 15, 2026 | |
| Murchinson Ltd. | 104.1K | 0.87% | May 15, 2026 | |
| Arete Wealth Advisors, LLC | 73.2K | 0.61% | May 20, 2026 | |
| LPL Financial LLC | 71.2K | 0.59% | May 6, 2026 | |
| UBS Group AG | 40.4K | 0.34% | May 5, 2026 | |
| Advisorshares Investments LLC | 24.5K | 0.20% | Apr 28, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 7.00% | 900.0K | 13G | Aug 14, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Joel Latham | director, officer: CEO and President | 806.2K | 6.74% | Nov 14, 2025 |
| Troy Valentine | director | 400.1K | 3.34% | Nov 14, 2025 |
| George Anastassov | director | 81.9K | 0.68% | Nov 14, 2025 |
| Peter Widdows | director | 65.3K | 0.55% | Nov 14, 2025 |
| Robert Clark | director | 59.6K | 0.50% | Nov 14, 2025 |
| Joseph Swan | officer: CFO, Treasurer and Secretary | 30.7K | 0.26% | Nov 14, 2025 |
2 people have not refiled in the last 18 months (24.7K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.